|

BCG Solution Clinical Trials

3 actively recruiting trials across 3 locations

Also known as: Bacillus Calmette Guerin Solution, Bacillus Calmette-Guerin Solution, TICE BCG Solution

Pipeline

Phase 3: 1Phase 4: 1Phase 1/2: 1

Top Sponsors

  • Ohio State University Comprehensive Cancer Center1
  • Mayo Clinic1
  • Alliance for Clinical Trials in Oncology1

Indications

  • Cancer3
  • Non-Muscle Invasive Bladder Carcinoma2
  • Stage 0a Bladder Cancer AJCC v82
  • Stage I Bladder Cancer AJCC v82
  • Recurrent Non-Muscle Invasive Bladder Carcinoma1

Birmingham, Alabama1 trial

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

University of Alabama at Birmingham Cancer Center

Phase 3

Jacksonville, Florida1 trial

In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial

Mayo Clinic in Florida

Phase 1/2

Columbus, Ohio1 trial

Studying the Relationship of Patient Positioning and Intravesical Bacillus Calmette Guerin Dwell Time to Improve the Treatment of Non-muscle Invasive Bladder Cancer

Ohio State University Comprehensive Cancer Center

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.